... Pharmacopro-teomic analysis of prechemotherapy and postchemotherapyplasma samples from patients receiving neoadjuvant or adju-vant chemotherapy for breast carcinoma. Cancer 2004,100:1814-1822.40. ... in personalized therapy for breast cancer. Clin Cancer Res 2008, 14:8019-8026.53. Hayashi S, Yamaguchi Y: Estrogen signaling pathway and hor-monal therapy. BreastCancer 2008, 15:256-261.54. ... patterns specific for healthy persons and breastcancer patientsAt first we compared the serum proteome patterns of 104healthy women and 92 early stagebreastcancer patients.Spectral components...
... Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer 2004, 100:1814-1822.32. ... usuallyexceeds 80%). Primary therapy for breastcancer is usuallybased on surgery, either radical or breast- conservingmastectomy. However, even in early stagecancer somepatients are at high risk ... analysis in diagnostics of breast cancer. Theseworks identified serum (or plasma) proteome patternsspecific for patients with breastcancer at either early orlate clinical stages [19-29]. Different...
... first-line chemotherapy in this study seems to indicate that this strategy should be recommended in patients with an ER or PgR positive tumour. Key words: Breast cancer; maintenance treatment; chemotherapy; ... treated for metastatic breastcancer in 4 French cancer centres. The diagnosis of metastasis was made between 1992 and 2002. A total of 772 patients received first-line chemotherapy [4]. Because ... HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREASTCANCER Armelle Dufresne 1, Xavier Pivot 2, Christophe Tournigand3,...
... now considered a standard of care in early breast cancers withN0 axillae; however, its role in locally advanced breastcancer (LABC) after neo -adjuvant chemotherapy (NACT) isstill being debated. ... advanced breast cancers (LABC).The current treatment guidelines for LABC focus uponmultimodality approach i.e. neo-adjuvant chemotherapy(NACT)followedbysurgeryandadjuvanttherapiesinthe form of chemotherapy, ... the effects of adjuvant chemotherapy [4-7].More recently, the indications for NACT have also beenextended to selected patients with an early staged dis-ease to allow breast conserving surgery...
... disease every year [2]. Although breastcancer is cur-rently the second most commo n cancer among Indianwomen (19%) after cervical cancer (30%), in the urban cancer registries of Delhi and Mumbai ... has rapidlyovertaken cervical cancer in frequency. In India majorityof breastcancer cases (30-50%) present at locallyadvanced stage [3] managed by neoadjuvant chemother-apy (NACT) in surplus ... chemotherapy inlocally advanced breastcancer patients. Additional workis necessary to elucidate the specific mechanisms bywhich the androgens and AR influences breast cancer cells proliferation...
... therapy versus conventional postopera-tive whole -breast radiotherapy after breast- conservingsurgery for the management of early -stage invasive breast cancer (a trial update). Amer J Surg 2007, 194:507-510.19. ... XB in the outpatient treatmentof early -stage breastcancer patients were recently pre-sented at the American Society of Clinical Oncology(ASCO) BreastCancer Symposium. Treatment with XBwas ... clinicalefficacy and safety for patients with early -stage breast cancer. BackgroundSeveral large randomized trials with extended follow-uphave shown that breast conserving therapy (BCT) offersequivalent...
... detect breast cancer. Clin Chem 2002;48(8): 1296–1304 27. Mathelin C. Cromer A, Wendling C, Tomasetto C, Rio MC: Serum biomarkers for detection of breast cancers: a prospective study. BreastCancer ... patients with pT1–2 breast cancer. Anticancer Res 2004; 24(5): 3221–3224. 11. Stein RC, Zvelebil MJ: The application of 2D gel-based prote-omics methods to the study of breast cancer. J Mammary ... early diagnosis of the BC. Key words: BreastCancer diagnosis, Serum Biomarkers, Bc1, Bc2, and Bc3 INTRODUCTION Breast cancer (BC) is the most common cancer among women in Westernized populations....
... recur-rent breastcancer with screening for second primary tumors in selected breast cancer survivors.EPIDEMIOLOGYExcluding cancers of the skin, breastcancer is the most common cancer among ... antigen for breastcancer surveillance is not recommended.Wellness is important to all breastcancer survivors but is especially important to those with favorable, early -stage breast cancer. To ... edition of BreastCancer continues the tradition of the M. D. Anderson Cancer Care Series. The book is oriented towards the needs of clinicians who manage breastcancer at every stage of the...
... D: Global cancer statistics. CA Cancer J Clin 2011, 61(2):69–90. 2. American Cancer Association: Survival rates for breast cancer. Atlanta: 2012. http://www .cancer. org /Cancer/ BreastCancer/OverviewGuide /breast- cancer- overview-survival-rates. ... earliest stages 0 and I respectively, compared to 15 % in stage IV [2]. Breast cancer is the most common cancer in Jordan, constituting 20 % of the total cancer cases and 22 % of the cancer deaths. ... about possible good prognosis of breast cancer when detected early. “My colleague, they discovered her breastcancer in early stages, she was healed after receiving chemotherapy; without a mastectomy”...
... and the Caribbean AfricaRegions Breastcancer Cervical cancer Ovarian cancer Corpus uteri cancer Colorectal cancer % of DALYs*percentage is based on all cancer deaths and DALYs lostFi g u ... American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors. CA Cancer J Clin 2007;57;7-28. 10. American Cancer Society. BreastCancer ... risk of breastcancer among post-menopausal women.” 22The burden of breast cancer in developing countriesRecent evidence shows that in middle-income develop-ing countries, breastcancer is...